Liver transplantation for non-hepatocellular carcinoma malignancies

Gregory J. Gores, Julie K. Heimbach, Charles B. Rosen

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD.

Original languageEnglish (US)
Pages (from-to)S22-S25
JournalLiver Transplantation
Issue numberSUPPL. 2
StatePublished - Oct 2010

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Liver transplantation for non-hepatocellular carcinoma malignancies'. Together they form a unique fingerprint.

Cite this